
The Botnar Institute of Immune Engineering (BIIE) is a newly founded research institute in Basel that serves as a hub for multidisciplinary science, uniting experts in immunology, bioengineering, computational biology, and AI. Our mission is to develop cutting-edge immune-based therapeutics and diagnostics by leveraging advanced computational tools.
Baxiva is a pre-seed biotechnology startup developing an advanced glycoconjugate vaccine targeting Extraintestinal pathogenic Escherichia coli (ExPEC), a leading cause of urinary tract infections and sepsis worldwide.
This position, based in Zurich, Switzerland, is a collaboration between the BIIE Molecular Mucosal Immunology group and Baxiva and offers the unique opportunity to work on cutting edge science with a focus on real-world clinical impact. If you are passionate about vaccinology and excited to collaborate in a diverse and dynamic environment, we encourage you to apply.
We are recruiting a Vaccine Immunologist to support development of a glycoconjugate vaccine targeting ExPEC. The Vaccine Immunologist will lead the generation and characterization of antigen-specific monoclonal antibodies for use as standards and controls and is expected to broadly support progress towards GLP compliant preclinical studies. This is a fixed appointment of 10 months with possibility to extend the engagement subject to progress and funding availability.
Your responsibilities will include:
The Molecular Mucosal Immunology group is dedicated to fostering creativity in science. As part of the team, you will receive hands on training in relevant methods and support for your professional and personal growth.
Essential:
Preferred:

The Botnar Institute of Immune Engineering (BIIE) is a non-profit research organisation focused on the advanced study of immunological systems with a mission to develop translational solutions for the diagnosis, treatment and prevention of disease. With this focus, the BIIE is committed to advancing global child and adolescent health. Outstanding investigators from around the globe will be recruited to its facility in Basel, Switzerland, to form a new hub of innovation in immune engineering. The Institute's mission is to harness the potential of immune engineering to enhance the lives of children and young people globally, and to deliver on the promise of a healthier future.
The BIIE is made possible by the generous endowment of over 1 Billion USD to be provided over 15 years from Fondation Botnar, a Swiss philanthropic foundation working to improve the health and wellbeing of young people around the world.